Current Neuro-Oncology
Volume
25 Number 14
31 July 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 14, 31 July
Bond KM, Curtin L, Hawkins-Daarud A, Urcuyo JC, De Leon G,
Singleton KW, Afshari AE, Paulson LE, Sereduk CP, Smith KA, Nakaji
P, Baxter LC, Patra DP, Gustafson MP, Dietz AB, Zimmerman RS,
Bendok BR, Tran NL, Hu LS, Parney IF, Rubin JB, Swanson
KR.
Image-based models of T-cell
distribution identify a clinically meaningful response to a
dendritic cell vaccine in patients with glioblastoma.
medRxiv
[Preprint]. 2023 Jul 16:2023.07.13.23292619∟.
doi: 10.1101/2023.07.13.23292619∟.
PMID: 37503239∟.
Interventional study. ˍ
Annakib S, Rigau V, Darlix A, Gozé C, Duffau H, Bauchet L,
Jarlier M, Fabbro M.
Bevacizumab in
recurrent WHO grades II-III glioma.
Front
Oncol. 2023 Jul 18;13:1212714∟.
doi: 10.3389/fonc.2023.1212714∟.
PMID: 37534252∟.
Observational study. ˍ
*
Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C,
Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M,
Taylor L, Vaillant B, Gill J, Kesari S.
An
expanded safety/feasibility study of the EMulate Therapeutics
Voyager™ System in patients with recurrent glioblastoma.
CNS
Oncol. 2023 Jul 18:CNS102∟.
doi: 10.2217/cns-2022-0016∟.
PMID: 37462385∟.
Interventional study. ˍ
Ghosh S, Johanns TM, Chheda MG, Liu
E, Butt O, Abraham C, Badiyan S, Huang Y, DeNardo D, Kim AH,
Hallahan D, Thotala D, Huang J.
A
pilot phase Ib study to evaluate tadalafil to overcome
immunosuppression during chemoradiotherapy for IDH-wild-type
glioblastoma.
Neurooncol
Adv. 2023 Jul 19;5(1):vdad088∟.
doi: 10.1093/noajnl/vdad088∟.
PMID: 37554225∟.
Interventional study. ˍ
Holdhoff M, Nicholas MK, Peterson RA, Maraka S, Liu LC, Fischer
JH, Wefel JS, Fan TM, Vannorsdall T, Russell M, Iacoboni M,
Tarasow TM, Hergenrother PJ, Dudek AZ, Danciu OC.
Phase
I dose-escalation study of procaspase-activating compound-1 in
combination with temozolomide in patients with recurrent
high-grade astrocytomas.
Neurooncol
Adv. 2023 Jul 19;5(1):vdad087∟.
doi: 10.1093/noajnl/vdad087∟.
PMID: 37554223∟.
Interventional study. ˍ
Lee MD, Patel SH, Mohan S, Akbari H, Bakas S, Nasrallah MP,
Calabrese E, Rudie J, Villanueva-Meyer J, LaMontagne P, Marcus DS,
Colen RR, Balana C, Choi YS, Badve C, Barnholtz-Sloan JS, Sloan
AE, Booth TC, Palmer JD, Dicker AP, Flanders AE, Shi W, Griffith
B, Poisson LM, Chakravarti A, Mahajan A, Chang S, Orringer D,
Davatzikos C, Jain R; ReSPOND Consortium.
Association
of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase
mutation in WHO grade 4 gliomas: results from the ReSPOND
consortium.
Neuroradiology.
2023 Jul 19∟.
doi: 10.1007/s00234-023-03196-9∟.
PMID: 37468750∟.
Observational study˰ ˍ
*
Lin H, Zhou X, Sheng X, Liang X.
Efficacy
and Safety of Apatinib in Patients with Recurrent
Glioblastoma.
Drugs R
D. 2023 Jul 19∟.
doi: 10.1007/s40268-023-00429-3∟.
PMID: 37466833∟.
Interventional study. ˍ
Umebayashi D, Naito K, Kurokawa R, Endo T, Mizuno M, Hoshimaru M,
Kim P, Hida K, Takami T; Neurospinal Society of Japan
Intramedullary Tumor Study Collaborators.
Epidemiology
and Comparative Analysis of Outcomes of Intramedullary Spinal Cord
Tumor Between Pediatric and Adult Patients.
Spine
(Phila Pa 1976). 2023 Jul 19∟.
doi: 10.1097/BRS.0000000000004775∟.
PMID: 37466205∟.
Observational study˰ ˍ
Buyuktepe M, Kaplan I, Bayatli E, Dogan H, Ugur HC.
Significance
of O6-methyl guanine methyltransferase promoter methylation in
high grade glioma patients: optimal cutoff point, CpG locus, and
genetic assay.
J
Neurooncol. 2023 Jul 20∟.
doi: 10.1007/s11060-023-04397-1∟.
PMID: 37474746∟.
Observational study˰ ˍ
Schmidt T, Agkatsev S, Feldheim J,
Oster C, Blau T, Sure U, Keyvani K, Kleinschnitz C, Stuschke M,
Herrmann K, Deuschl C, Scheffler B, Kebir S, Glas M, Lazaridis
L.
Feasibility
and tolerability of trofosfamide and etoposide in progressive
glioblastoma.
Neurooncol
Adv. 2023 Jul 20;5(1):vdad090∟.
doi: 10.1093/noajnl/vdad090∟.
PMID: 37547266∟.
Observational study. ˍ
Zhang YT, Wang Y, Zhong XD, Chang J.
Efficacy
of intrathecal methotrexate in children with high-risk
medulloblastoma over three years: a retrospective study from a
single center.
J
Neurooncol. 2023 Jul 20∟.
doi: 10.1007/s11060-023-04388-2∟.
PMID: 37474745∟.
Observational study. ˍ
Serra C, Türe H, Fırat Z, Staartjes VE, Yaltırık
CK, Ekinci G, Sav A, Türe U.
Microsurgical management of
midbrain gliomas: surgical results and long-term outcome in a
large, single-surgeon, consecutive series.
J
Neurosurg. 2023 Jul 21:1-12∟.
doi: 10.3171/2023.5.JNS222219∟.
PMID: 37503951∟.
Observational study. ˍ
Xu Q, Huang K, Meng X, Weng Y, Zhang L, Bu L, Zheng X, Cai J, Zhan
R, Chen Q.
Safety and Efficacy of
Anlotinib Hydrochloride Plus Temozolomide in Patients with
Recurrent Glioblastoma.
Clin
Cancer Res. 2023 Jul 21:CCR-23-0388∟.
doi: 10.1158/1078-0432.CCR-23-0388∟.
PMID: 37477938∟.
Observational study˰ ˍ
Alghamdi KT, Ashqar AA, Alamoudi A,
Alzahrani A, Samkari A, Kutub H.
Gliosarcoma
Invading the Temporal Bone, Temporalis Muscle, and Skull
Base.
Cureus.
2023 Jul 23;15(7):e42319∟.
doi: 10.7759/cureus.42319∟.
PMID: 37614263∟.
Case report. ˍ
Kirishima M, Akahane T, Takajo T, Higa N, Yonezawa H, Uchida H,
Kamimura K, Hanaya R, Yoshimoto K, Higashi M, Yoshiura T, Tanimoto
A.
A case of glioblastoma harboring
non-amplified epidermal growth factor receptor variant III:
Critical molecular detection using RNA-based panel
analysis.
Pathol Res
Pract. 2023 Jul 24;248:154712∟.
doi: 10.1016/j.prp.2023.154712∟.
PMID: 37499520∟.
Case report˰ ˍ
Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D,
Fernández-García P, Lladó V, McNicholl AG,
Rosselló CA, Taylor RJ, Azaro A, Rodón J, Sludden J,
Veal GJ, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escribá
PV.
A Phase 1/2A trial of idroxioleic
acid: first-in-class sphingolipid regulator and glioma cell
autophagy inducer with antitumor activity in refractory glioma.
Br
J Cancer. 2023 Jul 24∟.
doi: 10.1038/s41416-023-02356-1∟.
PMID: 37488446∟.
Interventional study. ˍ
Webb LM, Campian JL, Caron SJ, Roh M, Sener U.
A
rare case of glioblastoma with osseous metastases.
Can
J Neurol Sci. 2023 Jul 24:1-5∟.
doi: 10.1017/cjn.2023.256∟.
PMID: 37485667∟.
Case report˰ ˍ
Betbeder T, Moyer JD, Jeantrelle C, Decq P, Sigaut S.
External
validation of the Cranioscore for prediction of early
postoperative complications requiring ICU after brain tumor
craniotomy.
Anaesth
Crit Care Pain Med. 2023 Jul 25:101280∟.
doi: 10.1016/j.accpm.2023.101280∟.
PMID: 37499941∟.
Observational study˰ ˍ
Islam S, Inglese M, Grech-Sollars M, Aravind P, Dubash S, Barwick
TD, O'Neill K, Wang J, Saleem A, O'Callaghan J, Anchini G,
Williams M, Waldman A, Aboagye EO.
Feasibility
of [18F]fluoropivalate
hybrid PET/MRI for imaging lower and higher grade glioma: a
prospective first-in-patient pilot study.
Eur
J Nucl Med Mol Imaging. 2023 Jul 25∟.
doi: 10.1007/s00259-023-06330-0∟.
PMID: 37490079∟.
Interventional study. ˍ
Soykut ED, Odabasi E, Sahin N,
Tataroglu H, Baran A, Guney Y.
Re-irradiation
with stereotactic radiotherapy for recurrent high-grade glial
tumors.
Rep
Pract Oncol Radiother. 2023 Jul 25;28(3):361-369∟.
doi: 10.5603/RPOR.a2023.0034∟.
PMID: 37795399∟.
Observational study. ˍ
*
Wiese M, Pohlmeier B, Kubiak K,
El-Khouly FE, Sitte M, Carcaboso AM, Baugh JN, Perwein T,
Nussbaumer G, Karremann M, Gielen GH, Salinas G, Kramm
CM.
Boswellic
acid formulations are not suitable for treatment of pediatric
high-grade glioma due to tumor promoting potential.
J
Tradit Complement Med.
2023 Jul 25;14(1):101-108. doi:
10.1016/j.jtcme.2023.07.007. PMID:
38223806. Laboratory investigation. ˍ
De Bacco F, Orzan F, Crisafulli G, Prelli M, Isella C, Casanova E,
Albano R, Reato G, Erriquez J, D'Ambrosio A, Panero M, Dall'Aglio
C, Casorzo L, Cominelli M, Pagani F, Melcarne A, Zeppa P, Altieri
R, Morra I, Cassoni P, Garbossa D, Cassisa A, Bartolini A,
Pellegatta S, Comoglio PM, Finocchiaro G, Poliani PL, Boccaccio
C.
Coexisting cancer stem cells with
heterogeneous gene amplifications, transcriptional profiles, and
malignancy are isolated from single glioblastomas.
Cell
Rep. 2023 Jul 26;42(8):112816∟.
doi: 10.1016/j.celrep.2023.112816∟.
PMID: 37505981∟.
Laboratory investigation. ˍ
De Martino M, Daviaud C, Minns HE, Lazarian A, Wacker A, Costa AP,
Attarwala N, Chen Q, Choi SW, Rabadàn R, McIntire LBJ,
Gartrell RD, Kelly JM, Laiakis EC, Vanpouille-Box C.
Radiation
therapy promotes unsaturated fatty acids to maintain survival of
glioblastoma.
Cancer
Lett. 2023 Jul 26;570:216329∟.
doi: 10.1016/j.canlet.2023.216329∟.
PMID: 37499741∟.
Laboratory investigation˰ ˍ
Ganapathy S, Venkataramana NK, Nagaraj A, Panayotou G,
Panotopoulos C, Ronquist G.
Post-resection
Cavity Lavage of High Grade Glioma With a Novel Drug Combination:
A Case Report.
Anticancer
Res. 2023 Jul 26;43(8):3583-3588∟.
doi: 10.21873/anticanres.16537∟.
PMID: 37500132∟.
Case report˰ ˍ
*
Cohen KJ, Munjapara V, Aguilera D, Castellino RC, Stapleton SL,
Landi D, Ashley DM, Rodriguez FJ, Hawkins C, Yang E, London W, Chi
S, Bandopadhayay P.
A pilot study
omitting radiation in the treatment of children with newly
diagnosed Wnt-activated medulloblastoma.
Clin
Cancer Res. 2023 Jul 27:CCR-23-0348∟.
doi: 10.1158/1078-0432.CCR-23-0348∟.
PMID: 37498309∟.
Interventional study˰ ˍ
Fogg D, Gersey ZC, Pease M, Mallela AN, Andrews E, Plute T, Pearce
TM, Njoku-Austin C, Anthony A, Amankulor NM, Zinn P.
Outcomes
and treatment algorithm in glioblastoma patients 80 years and
older.
World Neurosurg.
2023 Jul 27:S1878-8750(23)01064-1∟.
doi: 10.1016/j.wneu.2023.07.116∟.
PMID: 37516146∟.
Observational study˰ ˍ
Wang Y, Jiao J, Yu T, Wang Z, Jiang W, Gong X, Zhang H, Yue J, Wu
M.
Independent Prognostic Factors and
Nomogram Prediction of Cancer-Specific Survival in Postoperative
Patients With Spinal Cord Astrocytoma.
Global
Spine J. 2023 Jul 27:21925682231191094∟.
doi: 10.1177/21925682231191094∟.
PMID: 37498194∟.
Observational study. ˍ
Chiang J, Bagchi A, Li X, Dhanda SK, Huang J, Pinto SN, Sioson E,
Dalton J, Tatevossian RG, Jia S, Partap S, Fisher PG, Bowers DC,
Hassall T, Lu C, Zaldivar-Peraza A, Wright KD, Broniscer A,
Qaddoumi I, Upadhyaya SA, Vinitsky A, Sabin ND, Orr BA, Klimo P,
Boop FA, Ashford JM, Conklin HM, Onar-Thomas A, Zhou X, Ellison
DW, Gajjar A, Robinson GW.
High-grade
glioma in infants and young children is histologically,
molecularly, and clinically diverse-Results from the SJYC07 trial
and institutional experience.
Neuro
Oncol. 2023 Jul 28:noad130∟.
doi: 10.1093/neuonc/noad130∟.
PMID: 37503880∟.
Observational study˰ ˍ
Prokop G, Wiestler B, Hieber D, Withake F, Mayer K, Gempt J,
Delbridge C, Schmidt-Graf F, Pfarr N, Märkl B, Schlegel J,
Liesche-Starnecker F.
Multiscale
quantification of morphological heterogeneity with creation of a
predictor of longer survival in glioblastoma.
Int
J Cancer. 2023 Jul 28∟.
doi: 10.1002/ijc.34665∟.
PMID: 37501565∟.
Observational study. ˍ
*
Van Gool SW, Makalowski J, Kampers
LFC, Van de Vliet P, Sprenger T, Schirrmacher V, Stücker
W.
Dendritic
cell vaccination for glioblastoma multiforme patients: has a new
milestone been reached?
Transl
Cancer Res. 2023 Jul 28;12(8):2224-2228∟.
doi: 10.21037/tcr-23-603∟.
PMID: 37701100∟.
Comment. ˍ
Refers
to: Liau
LM, et al. Association
of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With
Extension of Survival Among Patients With Newly Diagnosed and
Recurrent Glioblastoma: A Phase 3 Prospective Externally
Controlled Cohort Trial.
JAMA
Oncol. 2022 Nov 17∟.
doi: 10.1001/jamaoncol.2022.5370∟.
PMID: 36394838∟.
Interventional study. ˍ
Viozzi I, Overduin CG, Rijpma A, Rovers MM, Laan MT.
MR-guided
LITT therapy in patients with primary irresectable glioblastoma: a
prospective, controlled pilot study.
J Neurooncol.
2023 Jul 28∟.
doi: 10.1007/s11060-023-04371-x∟.
PMID: 37505379∟.
Interventional study. ˍ
Harat M, Rakowska J, Harat M, Szylberg T, Furtak J, Miechowicz I,
Małkowski B.
Combining amino acid
PET and MRI imaging increases accuracy to define malignant areas
in adult glioma.
Nat
Commun. 2023 Jul 29;14(1):4572∟.
doi: 10.1038/s41467-023-39731-8∟.
PMID: 37516762∟.
Observational study. ˍ
Mantica M, Drappatz J, Lieberman F, Hadjipanayis CG, Lunsford LD,
Niranjan A.
Phase II study of border
zone stereotactic radiosurgery with bevacizumab in patients with
recurrent or progressive glioblastoma multiforme.
J
Neurooncol. 2023 Jul 29∟.
doi: 10.1007/s11060-023-04398-0∟.
PMID: 37515669∟.
Interventional study˰ ˍ
Zaky W, Ragoonanan D, Batth I, Dao
L, Wang J, Xia X, Daw NC, Gill JB, Khatua S, Li S.
Automated
Capture and Analysis of Circulating Tumor Cells in Pediatric,
Adolescent and Young Adult Patients with Central Nervous System
Tumors.
Cancers
(Basel). 2023 Jul 29;15(15):3853∟.
doi: 10.3390/cancers15153853∟.
PMID: 37568669∟.
Observational study. ˍ
Wong LS, St George J, Agyemang K,
Grivas A, Houston D, Foo SY, Mullan T.
Outcomes
of Fluorescence-Guided vs White Light Resection of Glioblastoma in
a Single Institution.
Cureus.
2023 Jul 30;15(7):e42695∟.
doi: 10.7759/cureus.42695∟.
PMID: 37649945∟.
Observational study. ˍ
Neth BJ, Raghunathan A, Kizilbash
SH, Uhm JH, Breen WG, Johnson DR, Daniels DJ, Sener U, Carabenciov
ID, Campian JL, Khatua S, Mahajan A, Ruff MW.
Management
and Long-term Outcomes of Adults With Medulloblastoma: A Single
Center Experience.
Neurology.
2023 Jul 31:10.1212/WNL.0000000000207631∟.
doi: 10.1212/WNL.0000000000207631∟.
PMID: 37524533∟.
Observational study˰ ˍ
Sharma P, Medhi PP, Kalita AK,
Bhattacharyya M, Nath J, Sarma G, Yanthan Y.
Factors
Associated With Neurocognitive Impairment Following
Chemoradiotherapy in Patients With High-Grade Glioma: Results of a
Prospective Trial.
Brain
Tumor Res Treat. 2023 Jul 31;11(3):183-190∟.
doi: 10.14791/btrt.2023.0004∟.
PMID: 37550818∟.
Observational study. ˍ
Villy MC, Warcoin M, Filser M, Buecher B, Golmard L, Suybeng V,
Schwartz M, Bieche I, Vacher S, Laurence V, Bourdeaut F, Bernier
M, Gutman T, Stoppa-Lyonnet D, Masliah-Planchon J, Colas C.
First
report of medulloblastoma in a patient with MUTYH-associated
polyposis.
Neuropathol
Appl Neurobiol. 2023 Jul 31:e12929∟.
doi: 10.1111/nan.12929∟.
PMID: 37524406∟.
Case report˰ ˍ
Wang X, Sun Q, Wang W, Liu B, Gu Y, Chen L.
Decoding
key cell sub-populations and molecular alterations in glioblastoma
at recurrence by single-cell analysis.
Acta
Neuropathol Commun. 2023 Jul 31;11(1):125∟.
doi: 10.1186/s40478-023-01613-x∟.
PMID: 37525259∟.
Laboratory investigation. ˍ